314 results
Page 4 of 16
8-K
EX-99.1
f67woqwv2m1p2
16 Jul 20
Bristol Myers Squibb Announces Expiration and Final Results of Registered Exchange Offers
8:30am
8-K
EX-99.1
vtpw50u
16 Jun 20
Bristol Myers Squibb Announces Commencement of Registered Exchange Offers
8:39am
424B3
1fcxmbiou hot30nab
16 Jun 20
Prospectus supplement
8:01am
8-K
EX-99.1
smzbb j66g4in
7 May 20
Bristol Myers Squibb Reports Strong First Quarter 2020 Financial Results
8:08am
DEFA14A
243u3o2 7ygx
23 Apr 20
Additional proxy soliciting materials
8:59am
8-K
EX-99.1
tf4uoqi2ac7de2qj
25 Mar 20
Other Events
9:15am
8-K
EX-99.1
2l8e 3cszbr
6 Feb 20
Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results for 2019
8:20am
8-K/A
EX-99.1
ehyi 7v0gvqdof
5 Feb 20
Report of Independent Registered Public Accounting Firm
4:42pm
8-K
EX-99.1
q5pd1it1benmxaz3
31 Oct 19
Bristol-Myers Squibb Reports Third Quarter Financial Results
8:01am
8-K
y9ez3smu6m5bn7jiqq0
12 Sep 19
Bristol-Myers Squibb Board Announces Election of Three New Directors
5:27pm
8-K
EX-99.1
qnxfhx
12 Sep 19
Bristol-Myers Squibb Board Announces Election of Three New Directors
5:27pm
8-K
EX-99.1
kpc8giu z3jd
26 Aug 19
Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA® for $13.4 Billion
8:30am
8-K
EX-99.1
sqwd6
25 Jul 19
Bristol-Myers Squibb Reports Second Quarter Financial Results
8:21am
8-K
EX-99.1
5142gk6d8p1f9kk
5 Jun 19
Bristol-Myers Squibb Announces Post-Closing Leadership Team
8:24am
8-K
EX-99.1
wzucptiotvzcw vj
1 May 19
Other Events
8:30am